The rat has been used extensively as a model for human and animal renal diseases. Three types of model systems have been especially well researched.
Renal lesions occur quite frequently in rats, especially in aged rats. While the cause of these lesions is not known, experimental models suggest that some may be caused by immunopathologic processes. Three models have been particularly well characterized.
Immune complex nephritis has been studied using the autologous immune complex (AIC) nephritis or Heymann nephritis model (Figure 1 ). Rats which are repetitively immunized with suspensions of homologous homogenized kidney and Freund's adjuvant (intraperitoneally) develop moderate to marked proteinuria and slight endocapillary cellular proliferation. Immunofluorescent microscopy shows typical granular deposits along glomerular basement membranes (GBM). These granular deposits were shown by Edgington, Glassock, and Dixon (1) to be composed of the tubular brush border antigen RTE,5 and antibody to the brush border antigen. They hy-pothesized that AIC nephritis was induced when the homologous kidney suspension, containing brush border, induced autoantibody to RTE,s. This autoantibody then combined with intermittently released endogenous RTE,5, formed complexes which lodged in glomeruli, and caused chronic glomerulonephritis and proteinuria. Since antibody was readily detectable in the circulation and could transfer the disease to nonimmunized rats, it was theorized that immune complexes formed in antibody excess and then deposited in the kidney.
In another model, nephrotoxic serum nephritis (Masugi nephritis or NTS nephritis) renal lesions are produced in two stages when rats are injected with heterologous nephrotoxic antisera ( Figure 2 ). The NTS, produced against rat renal antigens and especially basement membranes, binds to rat GBM when injected. During this first or heterologous phase, caused by the heterologous antiserum, there is little histologic change in the rat's kidneys, although proteinuria shows a defect in GBM filtration function. As the rat produces antibody to the heterologous nephrotoxic serum bound on'GBM, the second or autologous phase begins. There may be neutrophil aggr~gation, thrombus formation and endocapillary cellular proliferation, induced by activation of the complement and coagulation sequences. Rats do not develop as s'evere lesions as do rabbits with NTS where frank glomerulosclerosis and crescent forrnation may occur.
Recently, there has been rather extensive work on inducible anti-tubular and anti-glomerular basement membrane disease in Brown-Norway (BN) and Lewis/BN hybrid rats (Figure 3) . These rats develop tubular lesions by 7-10 days after immunization with heterologous (bovine) or homologous tubular basement membrane (TBM) or GBM and adjuvant (Bordetella or Freund's). Kidneys taken from animals with this disease show focally raised white areas on the cortical surfaces (Figure 4) . These areas coalesce as the disease progresses. There is initially a linear binding of IgG and complement on TBM (Figure 5 ), followed by a peritubular neutrophilic infiltration (Figure 6) and then by a peritubular and interstitial lymphocytic, monocytic, and plasmacytic infiltration (Figure 7 ). Giant cells can be seen surrounding and phagocytizing tubules with lysed epithelium and split TBM (Figure 8 ). Depending on the amount and type of antigen (TBM, GBM), the route of administration, and the type of adjuvant used, between 50-90% of cortical tubules are destroyed by this antibody-complement mediated disease process. Robertson et al. (2) showed that if GBM is used as the antigen to induce the disease, there is more extensive tubular destruction, a more significant degree of biochemical abnormality (elevated BUN and serum chemistry; protein and glucose in urine) and a greater preponderance of glomerular lesions. GBM-induced glomerular lesions are of two types. There are ischemic lesions, seen as glomerulosclerosis and peri-glomerular fibrosis, caused by interruption in renal cortical blood flow as tubular lesions develop. There are also proliferative glomerular changes including linear fixation of IgG and complement on GBM (Figure Q seen in some cases of membranoproliferative glomerulonephritis (Figure 13) .
Rats immunized with GBM follow a rather fulminant course, frequently dying within 3 weeks of immunization. TBM-immunized rats have a much more benign course. In this regard, the GBM-immunized BN rat has a clinical course very much like the human affected by rapidly progressive glomerulonephritis.
These models illustrate the following points about rat renal immunopathology, and rat renal disease in general:
1. Rats can develop immune-complex and anti-basement membrane nephritis. 2. Rats develop autoantibodies to a variety of renal structural proteins (brush border, TBM, GBM). 3. It is possible that the age related changes 
